Pregnancy in women with prosthetic heart valves.

The pregnant woman with heart disease: management of pregnancy and delivery. Neth Heart J (2012) 0.90

Prosthetic valves in adult patients with congenital heart disease: Rationale and design of the Dutch PROSTAVA study. Neth Heart J (2012) 0.83

An audit of pregnant women with prosthetic heart valves at a tertiary hospital in South Africa: a five-year experience. Cardiovasc J Afr (2012) 0.81

Warfarin embryopathy: fetal manifestations. Virchows Arch (2010) 0.79

Expected and unexpected cardiac problems during pregnancy. Neth Heart J (2008) 0.79

Cardiac surgery and percutaneous intervention in pregnant women with heart disease. Neth Heart J (2012) 0.76

Prosthetic heart valve selection in women of childbearing age with acquired heart disease: a case report. J Med Case Rep (2016) 0.75

Outcomes of prosthetic valve replacement in women of child-bearing age. Surg Today (2016) 0.75

ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol (2006) 8.36

Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J (2007) 7.34

Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation (2001) 3.89

A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med (1993) 3.67

Venous thromboembolism during pregnancy. N Engl J Med (1996) 3.11

Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol (1999) 3.10

Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis. J Am Coll Cardiol (1997) 3.06

Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med (2000) 2.12

Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol (2007) 1.81

Prosthetic heart valves and pregnancy. Circulation (2003) 1.79

Long-term survival and valve-related complications in young women with cardiac valve replacements. Circulation (1999) 1.77

Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol (1989) 1.71

The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol (2001) 1.69

The impact of patient-prosthesis mismatch on late outcomes after mitral valve replacement. J Thorac Cardiovasc Surg (2007) 1.64

Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol (2003) 1.50

Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984-1996. Am J Obstet Gynecol (1998) 1.45

Cardiopulmonary bypass during pregnancy. Ann Thorac Surg (1996) 1.42

Plasma volume in normal first pregnancy. J Obstet Gynaecol Br Commonw (1973) 1.36

Outcome of pregnancy in women with valve prostheses. Br Heart J (1994) 1.27

Risk factors associated with cardiac surgery during pregnancy. Ann Thorac Surg (2003) 1.24

Valvular heart disease and pregnancy part I: native valves. J Am Coll Cardiol (2005) 1.22

Valvular heart disease and pregnancy: part II: prosthetic valves. J Am Coll Cardiol (2005) 1.22

Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol (1997) 1.20

Kidney function in pregnant women. Am J Kidney Dis (1987) 1.19

Diagnostic radiography in pregnancy: risks and reality. Aust N Z J Obstet Gynaecol (2004) 1.19

Cardiovascular changes in early phase of pregnancy. Am J Obstet Gynecol (1989) 1.17

Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol (1993) 1.17

Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. BJOG (2000) 1.12

Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy. Thromb Haemost (2004) 1.06

Clinical and echocardiographic assessment of pregnant women with valvular heart diseases--maternal and fetal outcome. Int J Cardiol (2004) 1.06

Primary aortic valve replacement with allografts over twenty-five years: valve-related and procedure-related determinants of outcome. J Thorac Cardiovasc Surg (1999) 1.04

Role of cine-fluoroscopy, transthoracic, and transesophageal echocardiography in patients with suspected prosthetic heart valve thrombosis. Am J Cardiol (2000) 1.00

Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis. Am J Cardiol (2003) 1.00

Late incidence and predictors of persistent or recurrent heart failure in patients with aortic prosthetic valves. J Thorac Cardiovasc Surg (2004) 0.99

Pregnancy in patients with pulmonary autograft valve replacement. Eur Heart J (1997) 0.96

Anticoagulation in pregnant women with mechanical heart valve prostheses. Heart (1999) 0.95

A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation. Am J Obstet Gynecol (2004) 0.93

Anticoagulation in pregnant women with prosthetic heart valves. J Cardiovasc Pharmacol Ther (2004) 0.91

[Prosthetic valve thrombosis in pregnancy. A single-center study of 12 cases]. Arch Mal Coeur Vaiss (2004) 0.87

Thrombolysis should be regarded as first-line therapy for prosthetic valve thrombosis in the absence of contraindications. J Am Coll Cardiol (2005) 0.85

Outcome of pregnancy in women after pulmonary autograft valve replacement for congenital aortic valve disease. J Heart Valve Dis (2007) 0.85

Teratogen update: fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis. Teratology (2002) 0.83

Doppler Echocardiography During Pregnancy: Physiological and Abnormal Findings. Echocardiography (1996) 0.82

Embryopathy associated with oral anticoagulant therapy. Birth Defects Orig Artic Ser (1976) 0.81

A case of prosthesis-patient mismatch complicating pregnancy. Am J Perinatol (2007) 0.81

The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon. Thromb Res (2008) 0.80

Prosthetic valve thrombosis: is it time for a new consensus conference? Eur J Echocardiogr (2008) 0.79

Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol (2008) 1.28

The relationship between anti-cyclic citrullinated peptide and bone mineral density and radiographic damage in patients with rheumatoid arthritis. Scand J Rheumatol (2008) 0.86

Is androgenetic alopecia a risk for atherosclerosis? J Eur Acad Dermatol Venereol (2009) 0.85

[Penetrating heart wounds. An analysis of 29 cases]. Ulus Travma Derg (2001) 0.75

The in vitro effect of beta-carotene and mitomycin C on SCE frequency in Down's syndrome lymphocyte cultures. Tohoku J Exp Med (1998) 0.75